Aluna, a provider of an AI-enabled patient-facing respiratory health management app for patients, raised $15.3 million in Series B funding.
Matrix Partners led the investment round with participation from Rho Ignition and Dr. Warner Carr, a California-based allergist whose practice is an early adopter of Aluna’s platform.
The Series B funding comes on the heels of a year of rapid growth, with Aluna adding thousands of new patients to its platform for a year-over-year growth rate of 10x. The company plans to invest both on the product and commercial side to produce more spirometers, make its offering more robust and reach new patients.
Including the latest round, Aluna has raised $27 million in equity funding to date.
With new funds, Aluna plans to commercialize its FDA-approved spirometer and AI-enabled respiratory health management app – that can help doctors provide respiratory care at scale. According to the company, its spirometer device and mobile app encourage patients to easily monitor and share their lung health data online with their doctor – anytime. This information helps doctors immediately identify respiratory diseases and provide customized treatment options for their patients.
Asthma
Asthma and Allergy Foundation of America data shows that roughly one in thirteen Americans has asthma, and this figure is increasing due to environmental factors. Asthma attacks lead to over one million emergency room visits each year, according to the American College of Asthma, Allergy & Immunology.
Investors
Founded in 1977, Matrix Partners is an early-stage VC firm. The firm has invested almost $1 billion in digital health startups to date; its latest investment portfolio includes – August Health, Casana, Mosaic Wellness, Centaur Labs, Anumana, nference, Practo, Weimai, Soyoung, 12 Sigma Technologies, DocTalk, Babytree, QPID Health, and Care.com.
“Aluna is paving the way for the entire healthcare system to discover the ways technology can change the lives of asthmatics,” said Antonio Rodriguez, General Partner at Matrix. “By combining the gold standard for measuring lung function with an innovative device, the cloud, and their proprietary algorithms, the company is giving superpowers to clinicians who can more effectively treat patients.”
According to our digital health investment database, virtual respiratory healthcare delivery startups have raised approximately $10 billion to date.
More recently, Sonde Health – a voice-enabled symptom detection and monitoring app for chronic and mental health conditions – raised $19.25 million in Series B funding. Partners Investment led the investment round with participation from NEOM Company, KT Corporation, and existing investors, including co-founder PureTech Health and M Ventures.
In another deal, NuvoAir, a provider of an app-connected spirometer that monitors respiratory diseases in real-time and shares information/alerts to patients and care providers, raised $11 million in funding led by Hikma Ventures.
Clinch here to learn more about digital Asthma startups…
